These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9496273)

  • 21. Manipulation of enteric flora in ulcerative colitis.
    Guslandi M
    World J Gastroenterol; 2005 Jun; 11(21):3327. PubMed ID: 15929195
    [No Abstract]   [Full Text] [Related]  

  • 22. Escherichia coli antibodies in patients with inflammatory bowel disease.
    Tabaqchali S; O'Donoghue DP; Bettelheim KA
    Gut; 1978 Feb; 19(2):108-13. PubMed ID: 344155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibodies against Escherichia coli in ulcerous colitis].
    Anselm K; LoGrippo GA; Hayashi H
    Z Gastroenterol; 1971; 9(9):648-50. PubMed ID: 4949181
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemorrhagic colitis and Escherichia coli O157:H7--identifying a messenger while pursuing the message.
    Harris AA
    Mayo Clin Proc; 1990 Jun; 65(6):884-8. PubMed ID: 2195249
    [No Abstract]   [Full Text] [Related]  

  • 25. Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues.
    Walmsley RS; Anthony A; Sim R; Pounder RE; Wakefield AJ
    J Clin Pathol; 1998 Sep; 51(9):657-61. PubMed ID: 9930068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shiga-like toxin production and connective tissue protein binding of Escherichia coli isolated from a patient with ulcerative colitis.
    Ljungh A; Eriksson M; Eriksson O; Henter JI; Wadström T
    Scand J Infect Dis; 1988; 20(4):443-6. PubMed ID: 3057620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum bactericidal resistance of faecal Escherichia coli and bactericidal competence of serum from patients with ulcerative colitis.
    Burke DA; Clayden SA; Axon AT
    J Clin Pathol; 1990 Apr; 43(4):316-9. PubMed ID: 2187904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of human immunoglobulins on microflora of the large intestine in nonspecific ulcerative colitis].
    Glad'ko IA; Pinegin BV; Korshunov VM; Khalif IL; Kirkin BV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):92-5. PubMed ID: 3518310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intestinal microflora in patients with nonspecific ulcerative colitis].
    Kosumian VKh; Kosumian TP
    Klin Med (Mosk); 1983 Jun; 61(6):72-4. PubMed ID: 6350701
    [No Abstract]   [Full Text] [Related]  

  • 30. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.
    Burke DA; Axon AT
    BMJ; 1988 Jul; 297(6641):102-4. PubMed ID: 3044496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli O:14 antigen.
    Perlmann P; Hammarström S; Lagercrantz R; Campbell D
    Proc Soc Exp Biol Med; 1967 Jul; 125(3):975-80. PubMed ID: 15938314
    [No Abstract]   [Full Text] [Related]  

  • 32. Ulcerative colitis and Escherichia coli with adhesive properties.
    Burke DA; Axon AT
    J Clin Pathol; 1987 Jul; 40(7):782-6. PubMed ID: 3305586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrophobic adhesin of E coli in ulcerative colitis.
    Burke DA; Axon AT
    Gut; 1988 Jan; 29(1):41-3. PubMed ID: 2893760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemorrhagic colitis due to Escherichia coli O103:H2 associated with infliximab therapy in a patient with rheumatoid arthritis.
    Kirchgatterer A; Weber T; Hinterreiter M; Knoflach P; Allerberger F
    Rheumatology (Oxford); 2002 Mar; 41(3):355-6. PubMed ID: 11934982
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes in the bacterial composition of feces contained in various portions of the large intestine and terminal portion of the ileum in patients with nonspecific ulcerative colitis].
    Levitan MKh; Marko OP
    Ter Arkh; 1970 May; 42(5):40-2. PubMed ID: 4915037
    [No Abstract]   [Full Text] [Related]  

  • 36. [The bacteriological and immunological efficacy of biosporin in nonspecific ulcerative colitis].
    Cherniakova VI; Bereza NM; Selezneva SI; Chaplinskiĭ VIa; Kudriavtseva VE; Mosalova NM; Shevtsova ZI; Tropko LV; Boĭko TI
    Mikrobiol Zh (1978); 1993; 55(3):63-7. PubMed ID: 8355632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three cases of hemorrhagic colitis in West Virginia due to Escherichia coli O157:H7.
    Battle EH; Elliott SY
    W V Med J; 1995; 91(7):320-1. PubMed ID: 8533400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An international study of agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species in Crohn's disease, ulcerative colitis and control subjects.
    Wensinck F; van de Merwe JP; Mayberry JF
    Digestion; 1983; 27(2):63-9. PubMed ID: 6628839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemorrhagic colitis due to Escherichia coli O157:H7 in Kenya.
    Sang WK; Saidi SM; Yamamoto H; Ezaki T; Iida T; Yoh M; Honda T
    J Trop Pediatr; 1996 Apr; 42(2):118-9. PubMed ID: 8984211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.